Fenofibrate Capsule
Product Images NDC 68180-130

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 68180-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fenofibrate (Fenofibratecapsulesag Figure 01)

FDA Label Image

Ndc 68180-130-06fenofibrate Capsules43 mgrx Only30 Capsules Lupin Pharmaceuticals, Inc. (Fenofibratecapsulesag Figure 02)

This is a medication called Fenofibrate, packaged in a bottle of 30 capsules. It is a prescription drug and each capsule contains 43mg of Fenofibrate. The usual dose is one capsule daily and it needs to be stored at a temperature of 25°C. The medicine was manufactured by Ethypharm Industries, in Saint Cloud, France, and distributed by Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, United States.*

FDA Label Image

Ndc 68180-131-06fenofibrate Capsules130 mgrx Only30 Capsules Lupin Pharmaceuticals, Inc. (Fenofibratecapsulesag Figure 03)

NDC 68180-131-06 is a medication called Fenofibrate available in capsules form. It is prescribed medication for which Rx is required. The usual recommended daily dose is one capsule. It should be stored tightly closed at a temperature of 25°C with permitted excursions to 15-30°C. The medication is manufactured by Ethypharm Industries in Saint Cloud, France, for Lupin Pharmaceuticals, Inc. located in Baltimore, Maryland.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.